Indonesia Blood Glucose Monitoring Devices Market

What is the Indonesia Blood Glucose Monitoring Devices Market Size?

As per the survey report on Indonesia blood glucose monitoring devices market, the market is expected to foresee a CAGR value of 7.1% during 2026-2036, and further generate a market size of USD 148.6 million by the end of 2036. In 2025, the market size was value at USD 63.8 million revenue.

• The Indonesia blood glucose monitoring devices market’s growth is driven by rising urbanization and lifestyle-related risks.
• KDMI analyst’s growth analysis foresees limited access in rural areas as restraint for Indonesia blood glucose monitoring devices market.
• In the Indonesia blood glucose monitoring devices market, type segment is playing significant role.

Indonesia Blood Glucose Monitoring Devices Market Analysis

Blood glucose monitoring devices are medical tools used to measure and track the concentration of sugar in human’s blood. These devices are essential for individuals managing conditions like diabetes, prediabetes, or hypoglycemia. The devices include a handheld meter and test strips to help monitor glucose levels. The Indonesia blood glucose monitoring device market is experiencing significant growth due to increasing prevalence of diabetes and growing awareness of the importance of glucose monitoring devices. Rapidly growing aging populations is one of the key factors supporting market growth. In 2024, there were 20.4 million adults aged 20-79 years, which is estimated to reach USD 28.6 million. Also, country’s medical device market was projected to reach USD 2.78 billion in 2025, driven by technological advancements. Therefore, supporting overall growth of Indonesia’s BGM devices market.

Indonesia Blood Glucose Monitoring Devices Market Growth Drivers and Restraints

Growth Drivers

• Rising urbanization and lifestyle-related risks – Rapid urbanization in Indonesia has significantly shifted dietary habits of individuals, contributing to a higher incidence of diabetes and thereby accelerating the need for advanced blood glucose monitoring devices. According to data, the urban population has expanded from 14% in 1960 to 56% in 2020 and is projected to increase by more than 70% by 2045. This leads to increased consumption of calorie-dense processed foods and sugar-sweetened beverages, which results in increased volume of lifestyle-related diseases. According to a national survey report, the prevalence of low physical activity in the population aged 10 years and above has increased from 26.1% in 2013 to 33.5% in 2018. This shift toward high-risk lifestyles is driving the need for frequent glucose monitoring as part of routine disease management.
• Expansion of home healthcare – In the country, home-based care is gaining traction, driven by healthcare costs hospital overcrowding, and patient preference for convenience. The adoption of telehealth services is rapidly increasing in the country, due to significant rise in elderly population by around 3% in 2021 and approximately 10.82% in 2022. According to a survey, 42% of older adults report health complaints and only 15% seek outpatient treatment. Therefore, this trend is further supported by the growth of teleconsultation services and pharmacy retail networks, which facilitate easy access to glucometers and consumables. Moreover, with the growing awareness about preventive healthcare solutions, patients are increasingly incorporating self-monitoring into their daily routines, thereby contributing to the market growth.

Restraints

• Limited access in rural and remote areas – The significant restriction is the country’s geographic spread, which creates challenges in distribution, logistics, and healthcare accessibility. Due to limited infrastructure, rural and remote areas lag behind in accessing advanced healthcare solutions, leading to untreated diseases, thereby impacting overall market growth.
• Affordability and reimbursement challenges – Despite of significant expansion in insurance coverage, accessing advanced treatment solutions require out-of-pocket expenses for devices and consumable that are not fully covered in insurance policies. This remains a key barrier for many patients, thereby slowing widespread adoption.

Indonesia Blood Glucose Monitoring Devices Market Segmentation

Our experts at KD Market Insights have segmented the Indonesia blood glucose monitoring devices market research report as:

Analyst’s Observation on Indonesia Blood Glucose Monitoring Devices Market Recent Developments

Over the years, the experts at KD Market Insights have been observing the recent developments associated with Indonesia blood glucose monitoring devices market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

BioHermes, in collaboration with strategic partner Ermatra, proudly supported the Indonesian Health Services Association (Adinkes) in hosting a seminar on diabetes management. The event, themed *Health Standards and Management of Diabetes Mellitus: The Role of HbA1c and Nutrition Based on Glycemic Index".

Smart Meter has announced the launch of iGlucose Plus, an advanced version of its patented cellular-connected glucose meter. The new iGlucose Plus is designed to enhance diabetes management for patients and healthcare providers by offering real-time blood glucose monitoring and multi-language capabilities.

Indonesia Blood Glucose Monitoring Devices Market Competitive Landscape

Some of the significant participants who top the Indonesia blood glucose monitoring devices market growth:

• Medtronic
• Roche
• Abbott
• Dexcom
• Novo Nordisk
• Eli Lilly
• Ascensia Diabetes Care
• Insulet Corporation
• Tandem Diabetes
• Ypsomed
• Sanofi
• Becton Dickinson
• GlucoModicum
• Philips-Medisize
• LifeScan (Johnson & Johnson)